|
|
|
|
Which protein expression system is the best fit for your protein target? Compare expression hosts based on protein complexity, scalability, cost, quality, and commercial production needs.
|
|
|
|
|
Securing a reliable supply of complex antigens and enzymes can be just as important as assay performance. Explore considerations for bypassing production bottlenecks, improving lot-to-lot consistency, and achieving rapid scalability.
|
|
|
|
|
Traditional cell line development can introduce challenges as manufacturing scales. See how transgenic fruit flies offer an alternative approach to stability, consistency, and bioreactor constraints.
|
|
|
|
|
Proper glycosylation is critical when selecting an expression platform. Explore how transgenic Drosophila produces functional glycosylated Erythropoietin as a case study and compare N-glycosylation patterns between conventional systems.
|
|
|
|
|
|
|
Step inside a fruit fly-based biomanufacturing facility for a closer look at how this alternative production model supports protein manufacturing from development through commercial scale.
|
|
|
|
|
|
|
|
|
Standard cell-free platforms often struggle with complex protein folding and post-translational modifications. We are currently developing a next-generation eukaryotic cell-free platform to address these bottlenecks. Connect with our scientific team to discuss technical parameters or join our early access list. Sign up here.
|
|
|